blue cross blue shield federal glp-1 coverage What FEHB changes mean for your 2026 health The Blue Cross and Blue

Oprah Winfrey has revealed that the GLP-1 weight loss medication she began taking in 2023 has unexpectedly curbed her desire to drink alcohol.

Activation of microglia in the trigeminal nucleus caudalis (TNC) contributes to this progression

This review underscores the necessity of early recognition, accurate diagnosis, and tailored interventions to mitigate complications and enhance patient outcomes

Learn About Their Benefits and Effectiveness.

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

A team of researchers from the University of Iowa has unveiled concerns about the use of semaglutide, a widely prescribed GLP-1 receptor agonist for type 2 diabetes and obesity, in patients with neuroendocrine neoplasms (NENs)